Lornoxicam
In Stock•Starting at $11 for 100 mg•Purity ≥ 98%
| CAS No. | 70374-39-9 |
|---|---|
| MDL No. | MFCD00866163 |
| MF | C13H10ClN3O4S2 |
| MW | 371.80 |
| InChI Key | WLHQHAUOOXYABV-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 100 mg | 98% | $11 | In Stock | |
| 250 mg | 98% | $15 | In Stock | |
| 1 g | 98% | $27 | In Stock | |
| 5*1 g | 98% | $128 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Lornoxicam is a thienothiazine-derived monocarboxylic acid amide formed by the condensation of the carboxy group of 6-chloro-4-hydroxy-2-methylthieno[2,3-e][1,2]thiazine-3-carboxylic acid 1,1-dioxide with the amino group of 2-aminopyridine. It is used for treating pain from inflammatory joint diseases, osteoarthritis, surgery, sciatica, and other inflammations. Lornoxicam functions as a non-steroidal anti-inflammatory drug, a non-narcotic analgesic, and an antipyretic. It is classified as a thienothiazine, a pyridine derivative, a monocarboxylic acid amide, an organochlorine compound, and a heteroaryl hydroxy compound.
| CAS No. | 70374-39-9 |
|---|---|
| Product Name | Lornoxicam |
Biological Targets
PTGS2·PTGS1
Associated Conditions
anti-neutrophil cytoplasmic antibody-associated vasculitis·rheumatic disease·Alzheimer disease·renal colic·migraine disorder·
* The information provided here is compiled from public sources and is for reference only.
